Occidental closed the chemicals chapter and spent the first half of the year proving the remaining company can throw off cash when crude cooperates. Richard Jackson's first quarter as chief executive arrived with a realized-oil spike, a midstream timing gift, and another large principal-debt paydown funded by the OxyChem sale to Berkshire Hathaway. That sale closed at an adjusted $9.5B. The Anadarko and CrownRock leverage argument is no longer the live debate. The live debate is who owns the residual once oil mean-reverts: common holders, or the eight percent preferred that still sits senior to them.
Face debt fell from $20.4B at year-end. Mid-year principal printed $11.8B. The preferred balance did not move. Berkshire still collects a $170M quarterly coupon on more than $8.3B of senior equity. That coupon now exceeds quarterly cash interest. Management lifted the common dividend a second time this year, to $0.28. The raise still sits far below the $4 annual distribution trigger that would force expensive preferred redemption. Midstream's headline pre-tax print includes derivative marks and asset gains. The oil price did the heavy lifting.
Domestic volumes cleared the top of guidance on Permian well delivery and Gulf of America uptime, offsetting weaker international barrels tied to Middle East disruption. That operating beat is real. What the next year has to resolve is whether Jackson can convert this oil-year cash into a $10B principal-debt print and a funded path to preferred retirement, or whether the common remains a junior claim on a price-taker whose multiple already assumes the repair is finished.